Adam C. Palmer
University of North Carolina at Chapel Hill(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, PARP inhibition in cancer therapy, Computational Drug Discovery Methods, Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Combination Cancer Therapy Can Confer Benefit via Patient-to-Patient Variability without Drug Additivity or Synergy(2017)647 cited
- → Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors(2016)478 cited
- → Understanding, predicting and manipulating the genotypic evolution of antibiotic resistance(2013)299 cited
- → Delayed commitment to evolutionary fate in antibiotic resistance fitness landscapes(2015)170 cited
- → Drug independence and the curability of cancer by combination chemotherapy(2022)157 cited
- → Opposing effects of target overexpression reveal drug mechanisms(2014)148 cited
- → A curative combination cancer therapy achieves high fractional cell killing through low cross-resistance and drug additivity(2019)139 cited
- → DT2216—a Bcl-xL-specific degrader is highly active against Bcl-xL-dependent T cell lymphomas(2020)125 cited
- → A Mathematical Model for Transcriptional Interference by RNA Polymerase Traffic in Escherichia coli(2004)119 cited
- → Transcriptional interference by RNA polymerase pausing and dislodgement of transcription factors(2011)105 cited